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Transformation of endocardial endothelial cells into invasive mesenchyme is a critical antecedent of cardiac cushion tissue formation.
The message for bone morphogenetic protein (BMP)-2 is known to be expressed in myocardial cells in a manner consistent with the
segmental pattern of cushion formation [Development 109(1990) 833]. In the present work, we localized BMP-2 protein in atrioventricular
(AV) myocardium in mice at embryonic day (ED) 8.5 (12 somite stage) before the onset of AV mesenchymal cell formation at ED 9.5.
BMP-2 protein expression was absent from ventricular myocardium throughout the stages examined. After cellularization of the AV
cushion at ED 10.5, myocardial BMP-2 protein expression was diminished in AV myocardium, whereas cushion mesenchymal cells started
expressing BMP protein. Expression of BMP-2 in cushion mesenchyme persisted during later stages of development, ED 13.5–16, during
valuvulogenesis. Intense expression of BMP-2 persisted in the valve tissue in adult mice. Based on the expression pattern, we performed a
series of experiments to test the hypothesis that BMP-2 mediates myocardial regulation of cardiac cushion tissue formation in mice. When
BMP-2 protein was added to the 16–18 somite stage (ED 9.25) AV endocardial endothelium in culture, cushion mesenchymal cells were
formed in the absence of AV myocardium, which invaded into collagen gels and expressed the mesenchymal marker, smooth muscle (SM)
a-actin; whereas the endothelial marker, PECAM-1, was lost from the invaded cells. In contrast, when noggin, a specific antagonist to
BMPs, was applied together with BMP-2 to the culture medium, AV endothelial cells remained as an epithelial monolayer with little
expression of SM a-actin, and expression of PECAM-1 was retained in the endocardial cells. When noggin was added to AV endothelial
cells cocultured with associated myocardium, it blocked endothelial transformation to mesenchyme. AV endothelium treated with BMP-2
expressed elevated levels of TGFh-2 in the absence of myocardium, as observed in the endothelium cocultured with myocardium. BMP-2-
supported elevation of TGFh-2 expression in endocardial cells was abolished by noggin treatment. These data indicated that BMP
signaling is required in and BMP-2 is sufficient for myocardial segmental regulation of AV endocardial cushion mesenchymal cell
formation in mice.
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Introduction tion of endocardial endothelial cells into invasive mesen-Valvuloseptal morphogenesis of the primitive heart
tube into a four-chambered organ requires the formation
of endocardial cushion tissue in two segments of the
primary heart tube, the atrioventricular (AV) canal, and
conus/truncus outlet (OT). In each segment, transforma-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights rserved.
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E-mail address: sugiy@musc.edu (Y. Sugi).chyme is a critical antecedent of cardiac cushion tissue
formation (Eisenberg and Markwald, 1995; Kisanuki et
al., 2001; Markwald et al., 1975, 1977). This transfor-
mation correlates spatially and temporally with the
mRNA expression of bone morphogenetic protein
(BMP)-2 and -4 in AV and OT myocardium (Lyons et
al., 1990; Jones et al., 1991; Yamada et al., 1999;
Yamagishi et al., 1999). BMPs, a subgroup of the trans-
forming growth factor (TGF)-h superfamily, are well
implicated in embryonic development (Branford et al.,
2000; Francis-West et al., 1994; Hogan, 1996; Wall and
Hogan, 1995). By using an in vitro culture assay system
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in AV cushion morphogenesis, that is, functional synergy
with TGFh-3 in AV epithelial–mesenchymal (E–M)
transformation (Yamagishi et al., 1999) and involvement
of the later phase of E–M transformation in chick
(Romano and Runyan, 2000). However, a recent paper
documented interspecies differences in molecular require-
ments between chicks and mice for cultured endocardial
cushion explants in AV canal morphogenesis (Camenisch
et al., 2002). Regarding mammalian development, BMP-
2-deficient mouse embryos exhibit a defect in cardiac
development and early embryonic lethality (Zhang and
Bradley, 1996). However, because the BMP-2-deficient
mice die on embryonic day (ED) 8.5 (Zhang and Brad-
ley, 1996) and BMP receptor (BMPR)-1A-deficient (Mis-
hina et al., 1995) and BMP-4-deficient (Lawson et al.,
1999) mice die up to ED 9.5, which is earlier than
cardiac cushion tissue formation, the role of BMPs was
not clear in AV canal cushion mesenchymal cell forma-
tion in mice. Therefore, to specifically elucidate the
functional role of BMP-2 during AV cushion formation
in mammals, we first explored its protein expression
pattern in developing mouse embryos. BMP-2 protein
was localized in mouse AV canal myocardium at ED
8.5 before AV cushion tissue formation, which occurs at
around ED 9.5. BMP-2 was not expressed in the endo-
cardium. After cardiac cushion tissue formation at ED
10.5, BMP-2 protein expression was diminished in the
AV myocardium and, instead, cushion mesenchyme
expressed BMP-2 protein.
Based on the protein expression pattern of BMP-2 in
mice, we sought to determine the role of BMP-2 during AV
cushion tissue formation by using collagen gel culture
assay for mouse embryos. In the present work, by using
carefully staged 16–18 somite stage (ED 9.25) mouse
embryos, we found that (1) exogenously added BMP-2
protein alone induced invasive mesenchymal cell formation
from AV endocardial epithelium of the ED 9.25 mouse in
the absence of myocardium; (2) the BMP antagonist
noggin blocked BMP-2-supported mesenchymal cell for-
mation from AV endothelium; (3) noggin blocked myocar-
dially supported mesenchymal cell formation from AV
endothelial cells; (4) up-regulation of cardiac cushion
mesenchymal cell formation marker, smooth muscle (SM)
a-actin, and down-regulation of the expression of the
endothelial marker, PECAM-1, were detected in BMP-2-
treated endocardial cells in the absence of myocardium; (5)
noggin blocked expression of SM-a actin and down-
regulation of PECAM-1 in endocardial epithelial cells
when treated with BMP-2 or cocultured with myocardium;
and (6) TGFh-2 expression was promoted in the endocar-
dial cells when treated with BMP-2 as well as cocultured
with AV myocardium. The promotion of TGFh-2 expres-
sion was inhibited when noggin was added to the culture.
Our findings lead us to conclude that the BMP pathway is
required in and BMP-2 is sufficient for E–M transforma-tion during AV cushion mesenchymal cell formation in
mice.
This work was partially reported in an abstract form
(Sugi et al., 1999).Materials and methods
Animals
C57BL/6 mice were kept at 23jC in a 12:12-h light/dark
cycle and allowed free access to water and a standard pellet
diet. Females were placed together with a male for 12 h, and
mating was confirmed by the presence of a vaginal sperm
plug. Pregnant mice were sacrificed by cervical dislocation
and a cesarean section was performed. Embryos were
collected in Earl’s-buffered saline (EBSS), and somite
number was counted to accurately determine the stages.
ED 9.25 embryos with 16–18 somites were used for the
collagen gel assay.
Immunohistochemical localization of BMP-2 in mouse
embryos
Anti-BMP-2 monoclonal antibody was kindly provided
by Genetics Institute (Boston, MA). It is a monoclonal
antibody raised against human BMP-2. Mouse BMP-2 has
87% homology with corresponding human sequences. Spec-
ificity of anti-BMP-2 was tested by indirect ELISA by the
manufacturer. The antibodies used for this study react with
BMP-2 and are not cross-reactive with other BMPs 3-7. In
the present study, specificity of BMP-2 in immunostaining
of the mouse embryonic tissue was verified by immunoab-
sorption. Anti-BMP-2 antibody was diluted to 1:500 (final
concentration of IgG was 2.7 Ag/ml) and preabsorbed with
270 Ag/ml recombinant human BMP-2 (Genetics Institute)
for 30 min at room temperature, followed by clarification at
13,000  g. This treatment abolished antibody staining in
mouse tissue sections (Fig. 1d).
Mouse embryos from ED 8.5 to 16.5 were fixed in
methanol at 20jC overnight. Adult mouse hearts were
also collected and fixed in methanol at 20jC. Samples
were embedded in low melting temperature (50–54jC)
paraffin, Paraplast X-TRA, to preserve antigenicity. Embed-
ded samples were stored at 20jC until sectioned at 5 Am.
Sections were deparaffinized with xylene and rehydrated in
a decreasing ethanol series. After rinsing with distilled water
and phosphate-buffered saline (PBS; pH 7.2), the sections
were incubated at room temperature with 10% normal goat
serum (ICN Pharmaceuticals, Aurora, OH) for 15 min to
block nonspecific binding. Sections were then incubated
with primary antibody, anti-BMP-2 (final concentration of
IgG, 2.7 Ag/ml in 1% bovine serum albumin (BSA)-PBS/
0.02% NaN3), primary antibody preabsorbed with BMP-2
as described above, or normal mouse IgG (2.7 Ag/ml in 1%
BSA-PBS/0.02% NaN3) as a negative control in a humid
Fig. 1. Immunohistochemical staining for BMP-2 protein in mouse embryonic day (ED) 8.5, 10.5, 13.5 and adult hearts. The antibodies used for this study have
been reported to react with BMP-2 and are non-cross-reactive with other BMPs (3–7) (Genetics Institute). (a) Intense immunoreactivity was detected in atrial
(A), AV canal, and outflow tract but not in the ventricular (V) myocardium or endocardium (E) at ED 8.5, which is before the onset of mesenchymal formation
(ED 9.5). (b) Higher magnification picture shows intense cytoplasmic staining in the AV myocardial cells (arrows in b) but not in the endocardial cells. (c) AV
myocardial expression diminished by ED 10.5, while BMP-2 protein expression was clearly detected in cushion mesenchymal cells (arrows in c) and in
epicardium (Ep). (d) Immnoabsorption abolished BMP-2 immunostaining in the adjacent section to c. (e) At ED 13.5, during valvulogenesis, cardiac valve
mesenchyme shows intense BMP-2 staining. Epicardial staining (Ep) became more prominent. Note that one part of cardiac valve expressed more prominent
staining than the other. This may be explained by the fact that part of cardiac valve tissue consists of myocardial tissue transformed from mesenchymal cells (de
la Cruz and Markwald, 1998). (f) BMP-2 protein expression persisted up to adult stage in cardiac valve tissue.
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fluorescein isothyocianate (FITC)-labeled rabbit anti-goat
IgG (ICN Pharmaceuticals) was applied for 1 h. After
rinsing, sections were mounted in DABCO (Sigma, St.
Louis, MO) in 90% glycerol/PBS. Immunostained sections
were examined under a Zeiss Axioscope.
Three-dimensional reconstruction of BMP-2 expression
Three-dimensional (3D) images were reconstructed by
the method previously described (Okagawa et al., 1995,
1996). Briefly, serial sections of ED 8.5 embryonic hearts
were observed under a Zeiss Axioscope and digital imageswere captured in a computer (Power Macintosh G3,
Apple, Cupertino, CA). External contours of the heart
and locations of BMP-2 immunoreactivity were digitized.
Data on 3D images were reconstructed for further rotation
and examination by NIH-image (W. Rasband, NIH,
Bethesda, MD).
Collagen gel assay for cushion mesenchyme formation
The preparation of hydrated collagen gel was modified
from Bernanke and Markwald (1982) and described previ-
ously (Yamamura et al., 1997). AV regions of the hearts
were dissected from the embryos. Each AV region was cut
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drained collagen gels (1 mg/ml, type I rat-tail collagen) that
had been saturated with the medium, OptiMEM (Gib-
coBRL, Grand Island, NY) supplemented with 1% heat-
inactivated fetal bovine serum (Hyclone, Logan, UT), ITS
(5 Ag/ml insulin, 5 Ag/ml transferrin, 5 ng/ml selenium,
Collaborative Research), and streptomycin/penicillin (Gib-
coBRL). Additional media were added to the cultures 2
h later and incubation was continued. For some explants,Fig. 2. Computer-aided three-dimensional reconstruction of an ED 8.5 mouse hear
The figure clearly shows that BMP protein expression confined to atrium, AV can
canal; OT: outflow tract; V: ventricle; LAO: left anterior orientation; L-lateral: lef
lateral: right lateral orientation; RPO: right posterior orientation.myocardium was removed after another additional 2 h of
incubation. To assess the biological activity of BMP-2
during E–M transformation, AV explants (endocardial–
myocardial coculture or endocardial culture without myo-
cardium) were treated with control OptiMEM alone, BMP-2
(200 ng/ml), or BMP-2 (200 ng/ml) + noggin, an antagonist
to BMPs (Zimmerman et al., 1996) (500 ng/ml). Recombi-
nant human BMP-2 was a generous gift from Genetics
Institute, Inc. (Cambridge, MA). Recombinant human nog-t showing outer surface (blue) and sites of BMP-2 protein expression (red).
al, and outflow tract but not in the ventricle. A: atrium; AV: atrioventricular
t lateral; LPO: left posterior orientation; RAO: right anterior orientation; R-
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Inc. (Tarrytown, NY). Mesenchymal formation was
assessed at 48 h by counting the number of invasive
mesenchymal cells in the collagen gel with an inverted
microscope equipped with Hoffman optics (Olympus, IMT-
2). Culture was not considered to be mesenchymal unless
greater than three mesenchymal cells were observed beneath
the surface of the gel as previously described (Yamamura et
al., 1997).
Immunohistochemistry of collagen gel-cultured mouse AV
explants
AV explants were processed for whole-mount immunos-
taining. Cultured explants were drained of medium, rinsed
with PBS, fixed with methanol at 20jC for 1 h, rinsed
with PBS and blocked for 1 h with 10% normal goat serum
(ICN, Cappel, Aurora, OH) with 1% BSA (Sigma) in PBS.
After incubation at 4jC overnight with primary antibodies,
anti-PECAM-1 (CD31) (Pharmingen, San Diego, CA), anti-
SM a-actin (Sigma), or anti-TGFh-2 (Santa Cruz, CA),Fig. 3. AVendocardial monolayers from ED 9.25 (16–18s) mice were treated with
in the absence of the myocardium; a, c, and e surface view; b, d, and f deep view
treated with BMP-2 showed cell–cell separation (arrow heads in a) and invasi
abolished when noggin was added to the medium and endocardial monolayer gre
cultured with control OptiMEM alone did not show E–M transformation (e andsamples were rinsed and incubated with either tetramethylr-
hodamine isothiocyanate (TRITC) or FITC-conjugated sec-
ondary antibodies (ICN). Anti-PECAM-1, which was raised
against mouse PECAM-1, was purchased from Pharmingen.
PECAM-1 has been used as a mouse endothelial cell marker
(Baldwin et al., 1994). Anti-SM a-actin has been used as a
mesenchymal marker for cardiac cushion cells in mice
(Yamamura et al., 1997) and was purchased from Sigma.
Anti-TGFh-2 was raised against a peptide corresponding to
amino acids 352–377 mapping at the carboxyterminus of
TGFh-2 of human origin, which has 90% homology with
mouse TGFh-2. Anti-TGFh-2 reacts with TGFh-2 of mouse
origin in Western blotting and immunoprecipitation and
immunohistochemistry and is non-cross-reactive with either
TGFh-1 or TGFh-3 by manufacturer (Santa Cruz Biotech-
nology, Santa Cruz, CA). In the present study, specificity of
TGFh-2 in immunostaining of the mouse embryonic tissue
was verified by immunoabsorption. Anti-TGFh-2 antibody
was diluted to 1:100 (final concentration of IgG was 1 Ag/
ml) and preabsorbed with 100 Ag/ml immunogenic peptide
(Santa Cruz Biotechnology) for 30 min at room temperature,BMP-2 (a and b), BMP-2 + noggin (c and d), or control OptiMEM (e and f)
in the collagen gels (80 Am from the surface). AV endocardial monolayer
ve mesenchymal cell formation (arrowheads in b). Effect of BMP-2 was
w and extended on the surface of the gel (c and d). Endocardial monolayer
f).
Table 1
Quantitative summary of mesenchyme formation
Culture conditions Mesenchymal cell
Fig. 4. AV endocardial explants from ED 9.25 (16–18s) mice were treated with control OptiMEM or noggin in the presence of myocardium; a and c surface
view; b and d deep view in the collagen gels (80 um from the surface). When cocultured with AV myocardium, AV endocardium formed invasive
mesenchyme (arrowheads in b). Note that mouse endocardial endothelium did not form extended monolayer on the surface of the collagen gels. All of the
endothelial cells lost cell – cell contacts and subsequently invaded into the collagen gels (arrowheads in b). Invasive mesenchymal cell formation was abolished
when AV endocardium was treated with noggin in the presence of myocardium (c and d).
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abolished antibody staining in mouse AV cultures (not
shown). Samples were rinsed, mounted with DABCO
(Sigma), in 90% glycerol/PBS after an antiquench mounting
medium, and observed under a fluorescent microscope
(Leica, BMLB) or with confocal microscopy using a Bio-
Rad MRC-1000 Laser Scanning Confocal Imaging System.
TGFb-2 immunointensity in cultured endocardial cells
The original photo was taken under a Laser Scanning
Confocal-Microscope (Bio-Rad MRC-1000) equipped with
Zeiss Axioscope. For each sample, the same condenser iris
opening (4.0) and 30% laser was applied. TGFh-2 immu-
nointensity was evaluated by measuring the intensity of
TGFh-2 immunofluorescence using the computer software,
Adobe Photoshop 5.5 (Adobe Systems, Inc., San Jose, CA).
Average fluorescence intensity of the cultured epithelial and
mesenchymal cells was normalized by subtracting the
fluorescence intensity in the background of each photo.formation by 48 h
AV endocardium alone Frequency
OptiMEM 0/8 (0%)
OptiMEM + BMP-2 7/8 (88%)
OptiMEM + BMP-2 + Noggin 0/9 (0%)
AV endocardium + myocardium
OptiMEM 6/6 (100%)
OptiMEM + Noggin 0/8 (0%)
Frequency—number of AV endocardium forming mesenchymal cells by
48 h. Mesenchymal cell formation was determined by observing more than
three cells beneath the surface of the collagen gels.Results
Immunohistochemical localization of BMP-2 in AV cushion
formation and subsequent valvulogenesis
Antibody localization of BMP-2 was performed in em-
bryonic mouse hearts at ED 8.5–16.0 and in adult hearts.
The antibodies used for this study react with BMP-2 and arenot cross-reactive with other BMPs 3-7 according to the
manufacturer (Genetics Institute). The specificity of BMP-2
in immunostaining of the mouse embryonic tissue was
verified by immunoabsorption (see details in Materials
and methods). This treatment abolished BMP-2 antibody
staining in mouse sections (Fig. 1d). Intense cytoplasmic
staining was detected in atrial, AV canal, and OT myocar-
dium but not in the ventricular myocardium or endocardium
at ED 8.5 (Figs. 1a and b). Computer-aided three-dimen-
sional reconstruction of the ED 8.5 mouse heart stained with
BMP-2 antibodies clearly indicated that BMP protein ex-
pression was confined to dorsal wall of the atrium, AV
canal, and OT but not in the ventricle (Fig. 2). This
expression pattern persisted up to ED 9.5 at the onset of
AV cushion formation in mice, which provided the basis of
Y. Sugi et al. / Developmental Biology 269 (2004) 505–518 511the experimental design to address the role of BMP-2 during
AV valvulogenesis. After cushion mesenchymal cell forma-
tion occurred, BMP-2 expression was diminished in the
myocardium of the AV canal and associated atrium. Instead,
BMP-2 was clearly localized in the AV cushion mesenchy-
mal cells (Fig. 1c). When valvulogenesis proceeded to later
stages, BMP-2 continued to be localized in mesenchymal
cells in AV valvular mesenchyme and AV septum (Fig. 1e).Fig. 5. AV endocardial monolayer treated with control OptiMEM alone (a and b),
(g and h) was double immunolabeled with the endocardial endothelial marker, PECA
actin (RITC, red color, b, d, f, and h). PECAM-1 expression was retained in the end
(a) or BMP + noggin (e), while there was little expression of PECAM-1 in the expl
expression was detected in invasive mesenchymal cells in the explants treated with
with OptiMEM alone (b) or BMP-2 + noggin (f).However, in certain areas, valve tissue appeared to loose
BMP-2 immunostaining during valvulogenesis. This may be
explained by the fact that parts of valve mesenchyme may
have been replaced by myocardial cells, which differentiated
from mesenchymal cells during valvulogenesis (de la Cruz
and Markwald, 1998; Van den Hoff et al., 2000). BMP-2
protein remained expressed in valve leaflets up to the adult
stage (Fig. 1f).BMP-2 (c and d), BMP + noggin (e and f), or cocultured with myocardium
M-1 (FITC, green color, a, c, e, and g), and the mesenchymal marker, SM a-
ocardial endothelial cells in the explants treated with control OptiMEM alone
ants treated with BMP-2 (c) or cocultured with myocardium (g). SM a-actin
BMP-2 (d) or cocultured with myocardium (h) but not in the explants treated
tal Biology 269 (2004) 505–518BMP-2 induced cell–cell separation and invasive
mesenchymal cell formation (E–M transformation) from AV
endocardial endothelial cells in the absence of myocardium
AVendocardial endothelium is composed of an epithelial
monolayer at ED 9.25 (16–18 somite stage). AV endocar-
dial cushion transformation occurs between 21 and 28
somite stages (ED 9.5) in mice (Camenisch et al., 2002).
Because after the 20–21 somite stage, transformation of
endocardial epithelial cell to mesenchymal cell (E–M
transformation) was often observed in our collagen gel
culture assay system without any treatments, only mouse
embryos with 16–18 somites were carefully selected for the
AV E–M transformation assay. Under the condition of our
Y. Sugi et al. / Developmen512Fig. 6. TGFh-2 expression in AVendocardial explants treated with control OptiME
cocultured with myocardium (b), or treated with noggin in the presence of myocar
OptiMEM alone (a), BMP + noggin (d), or cocultured with myocardium and tre
Similar to the effect of myocardial coculture (b), endocardial cells treated with BM
TGFh-2 staining in the cytoplasm. The effect of BMP-2 or myocardium was abomouse AV bioassay system, when cultured with control
OptiMEM, the endocardial epithelial monolayer did not
extend peripherally as seen in chick AV transformation
assay but remained as an epithelial cells on the surface of
the collagen gel (Figs. 3e and f, also see Yamamura et al.,
1997). When 200 ng/ml BMP-2 was added to the culture,
cell–cell separation and subsequent invasive mesenchymal
cell formation (E–M transformation) occurred within 48
h (Figs. 3a and b). The same results were obtained when 100
ng/ml of BMP-2 was used in the culture assay (data not
shown). Noggin blocked BMP-2-supported cell–cell sepa-
ration and subsequent invasive mesenchymal cell formation
in AV endocardial endothelial cells. In the presence of
noggin, extended epithelial monolayers were consistentlyM alone (a), BMP-2 (c), BMP + noggin (d) in the absence of myocardium or
dium (e). Endocardial monolayer cells formed after treatments with control
ated with noggin (e) demonstrated weak dotlike staining in the cytoplasm.
P-2 (c) formed invasive mesenchymal cells and expressed elevated level of
lished when noggin was added to AV endocardial explants (d and e).
Fig. 7. Quantitative evaluation of AV endocardial endothelial cells
immunostained with anti-TGFh-2. The data represent the average of
TGFh-2 immunostaining intensity from multiple endocardial epithelial cells
or mesenchymal cells. The average of immunointensity of endocardial
epithelial cells within explant cultured with OptiMEM alone was used as
control intensity (Endo only). Immunointensity of invasive mesenchymal
cells formed after the treatment of myocardial coculture (Endo/Myo) or
BMP-2 treatment (Endo + BMP-2) is significantly higher than control
(Endo only) (*P < 0.05, Student’s t test). There is no significant difference
in TGFh-2 immunointensity of endocardial epithelial cells in the explants
treated BMP + noggin (Endo + BMP-2 + Noggin) or cocultured with
myocardium and treated with noggin (Endo/Myo + Noggin).
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that noggin, an antagonist of BMP-2/4, blocked the effect of
exogenously added BMP-2 in the E–M transformation
assay in mouse AV explants. These data indicated that
BMP-2 could induce E–M transformation from mouse AV
endocardial endothelial cells.
Noggin inhibited cell–cell separation and invasive
mesenchymal cell formation (E–M transformation) from AV
endocardial endothelial cells cultured in the presence of
myocardium
AV endocardial endothelium from the 16–18 somite
stage (ED 9.25) mouse embryos formed invasive mesen-
chymal cells within 48 h when cocultured with associated
myocardium in control OptiMEM (Figs. 4a and b). Note that
mouse AV endocardial endothelium, which was cocultured
with myocardium, did not form a large epithelial monolayer
as typically observed in chick AV explants (Figs. 4a and b,
also see Yamamura et al., 1997). When noggin was added to
AV endocardial endothelium cocultured with associated
myocardium, cell–cell separation and subsequent invasive
mesenchymal cell formation (E–M transformation) were
completely abolished and instead a large endocardial epi-
thelial monolayer was formed on the surface of collagen
gels (Figs. 4c and d). These data evidenced that BMP
signaling was required in AV E–M transformation sup-
ported by AV myocardium in mice. Table 1 summarizes
results obtained from collagen gel culture assays.
Markers for E–M transformation affirmed invasive
mesenchymal cell formation in AV explants
PECAM-1 has been known to be expressed in mouse
endothelial cells but down-regulated during their E–M
transformation in the AV canal (Baldwin et al., 1994).
Conversely, SM a-actin is expressed in invasive mesenchy-
mal cells after complete E–M transformation but not in the
endocardial epithelial cells in chick and mouse explants
(Nakajima et al., 1997; Yamamura et al., 1997). Therefore,
expression of these two molecules was used as makers for
further determining the characteristics of the cells, either
endothelial or mesenchymal, in the present study. Expres-
sion of epithelial marker PECAM-1 was retained in the
endocardial endothelial cells when AV endocardial epitheli-
um was cultured with control OptiMEM alone or BMP-2 +
noggin in the absence of myocardium (Figs. 5a and e).
Double immunohistochemistry of PECAM-1 and SM a-
actin demonstrated that the explants that expressed
PECAM-1 in endothelial cells, which were treated with
either OptiMEM alone or BMP-2 + noggin, did not express
the mesenchymal marker, SM a-actin (Figs. 5b and f).
Conversely, SM a-actin was detected only in the explants
that formed invasive mesenchymal cells, which were either
treated with BMP-2 or cocultured with myocardium (Figs.
5d and h). The expression pattern of E–M transformationmarkers, PECAM-1 and SM a-actin, affirmed the results
observed by Hoffman optics, in which BMP-2 as well as AV
myocardium induced E–M transformation of AV endocar-
dium in collagen gel-cultured mouse explants. Taken to-
gether, these data further supported our hypothesis that
BMP-2 is a sufficient and essential inducer in E–M trans-
formation supported by AV myocardium in mice.
BMP-2 as well as myocardium induced TGFb-2 expression
in AV endocardial cells
Elevated expression of TGFh-2 mRNA has been ob-
served in mouse AV cushion mesenchyme coincident with
E–M transformation in vivo (Camenisch et al., 2002; Molin
et al., 2003). A recent paper documented that TGFh-2 but
not TGFh-3 was required in AV E–M transformation in
mice (Camenisch et al., 2002). Therefore, in this work, we
sought to address the interaction of myocardially derived
BMP-2 and endocardially expressed TGFh-2 on the AV E–
M transformation in mice.
When AV endocardium was cultured in OptiMEM alone
in the absence of the myocardium, all cells remained on the
Y. Sugi et al. / Developmental Biology 269 (2004) 505–518514surface of the collagen gels and a weak punctate cytoplas-
mic expression of TGFh-2 was observed in endocardial
epithelial cells (Figs. 6a and 7). When AV endocardium was
cultured in OptiMEM in the presence of associated AV
myocardium, endocardial cells transformed into invasive
mesenchymal cells and those cells exhibited a significant
increase of TGFh-2 immunointensity in the cytoplasm
(Figs. 6b and 7). Similarly, increased TGFh-2 was detected
in the invasive mesenchymal cells when endocardial endo-
thelium was treated with BMP-2 in the absence of myocar-
dium (Figs. 6c and 7). Noggin blocked BMP-2 or
myocardially supported increases in TGFh-2 expression inFig. 8. Summary diagram showing the results of bioassay to assess the role of B
explants. Mouse embryos at ED 9.25 with 16–18 somites were used for the co
endocardial monolayer cultured with OptiMEM in the presence of the myocardium
actin and TGFh-2 and lost PECAM-1. Noggin treatments inhibited myocardially
SM a-actin, and TGFh-2 expression. Endocardial monolayer remained on the
Endocardial monolayer cultured with OptiMEM in the absence of myocardium d
condition, invasive mesenchymal cell formation (E–M transformation) occurred
atrioventricular canal; End: endocardium; Myo: myocardium; OT: outflow tract;endocardial endothelial cells (Figs. 6d and e and 7). These
experimental data are summarized in Fig. 8.Discussion
Transformation of the AV canal endocardium into inva-
sive mesenchyme called ‘‘cushion tissue’’ is a critical
antecedent for valvuloseptal morphogenesis. Myocardially
derived factors are implicated in the induction of the
mesenchymal cell formation from AV endothelial explants
(Eisenberg and Markwald, 1995; Krug et al., 1985, 1987;MP-2 during epithelial–mesenchymal (E–M) transformation in mouse AV
llagen gel assay. Results were evaluated 48 h after the explantation. AV
formed invasive mesenchymal cells, which expressed SM a-smooth muscle
supported invasive mesenchymal cell formation and mesenchymal markers,
surface of the collagen gels and retained PECAM-1 endothelial marker.
id not transform and remained epithelial. When BMP-2 was added to this
. Noggin blocked BMP-2-supported E–M transformation. A: atrium; AV:
*, weak dot-like immunostaining.
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Mjaatvedt et al., 1987, 1991). Specifically, myocardium in
the AV canal but not in the ventricle has the potential to
induce AV endocardial cells to transform into cushion
mesenchymal cells (Mjaatvedt et al., 1987; Runyan and
Markwald, 1983). Messenger RNA for BMP-2 has been
localized in the AV canal and OT but not in the ventricular
myocardium in mouse (Abdelwahid et al., 2001; Lyons et
al., 1990) and chick (Yamada et al., 1999; Yamagishi et al.,
1999) hearts at the time coincident with the AV cushion
formation. Our present work is the first study to explore the
expression pattern of BMP-2 protein in developing mouse
hearts including stages before and after AV cushion forma-
tion. BMP-2 protein was expressed in AV, OT, and atrial
myocardium but not in the ventricle or endocardium in
mouse hearts at ED 8.5 before AV cushion mesenchyme
formation (Figs. 1 and 2). This expression pattern persisted
up to ED 9.5, the onset of AV cushion formation. There
were no fundamental differences in expression patterns
between BMP-2 protein and its reported mRNA in devel-
oping mouse myocardium (Lyons et al., 1990). In the
present work, we found that BMP-2 protein expression
was diminished in myocardium after the onset of AV E–
M transformation whereas BMP-2 expression became evi-
dent in the cytoplasm of AV cushion mesenchymal cells,
which remained positive throughout all stages of valvulo-
genesis including the adult stage.
By using well-established collagen gel culture assays for
chick embryos, BMP-2 was previously implicated in AV
cushion morphogenesis, that is, functional synergy with
TGFh-3 in E–M transformation (Nakajima et al., 2000;
Yamagishi et al., 1999). Yamagishi et al. (1999) reported
that BMP-2 promoted AV E–M transformation when BMP-
2 was added together with TGFh-3 in a chick AV explant
culture. However, our data suggested that BMP-2 alone can
elicit AV E–M transformation in our mouse culture assay
(Figs. 3 and 5) The apparent discrepancy might be derived
from differences in species (mouse vs. chick) or differences
in experimental designs and procedures. Distinct interspe-
cies differences between mice and avian embryos were
recently reported with respect to expression pattern and
function of TGFh-2 and TGFh-3 during AV cushion tissue
formation (Camenisch et al., 2002). Data from Camenisch et
al. (2002) indicated that TGFhs did not have the same
ligand specificity in AV canal morphogenesis in mice as in
chick embryos. Therefore, different molecular requirements
for BMP-2 might explain why BMP appears more indis-
pensable in mouse AV E–M transformation than it does in
chick.
In our mouse AV explants assays, we carefully selected
16–18 somite stage (ED 9.25) mouse embryos for transfor-
mation assays since E–M transformation occurs in AV
endothelial cells from embryos older than the 20–21 somite
stage without any treatment or the presence of myocardium
in the control medium (data not shown, also see Yamamura
et al., 1997). These data are consistent with the in vivoobservation, which indicates that AV cushion formation
occurs between 21 and 28 somites for mouse embryos
(Camenisch et al., 2002). Endocardial endothelial cells from
16 to 18 somite embryos do not transform in the control
medium in the absence of the myocardium (Fig. 3 and Table
1). Therefore, it is unlikely that our findings were the result
of the endocardium being preactivated before BMP-2 was
exogenously added to the culture nor it is likely to be a
dosage effect. For example, Yamagishi et al. (1999) used 1
Ag/ml for chick AV culture assays vs. 200 ng/ml we used
for our mouse assays. We also observed the same biological
response at 100 ng/ml BMP-2 in the mouse AV cushion
formation assay (data not shown). BMP-2, as a member of
the TGFh superfamily, is known to affect the biological
responses in a dose-dependent manner. The dosage used in
functional assays ranged from 50 (Lough et al., 1996) to
200 ng/ml (Schultheiss et al., 1997) in primary culture
assays for heart formation from precardiac mesoderm, and
an inhibitory reaction was observed with the higher dosage
of BMP in heart formation assays (Ladd et al., 1998). Thus,
the higher levels of BMP-2 may have inhibited BMP-2
pathway resulting in the addition of TGFh-3 to complete
the transformations.
Another discrepancy found between the present mouse
data and chick experiments was related to the effects of
noggin, an antagonist to BMPs in E–M transformation. In
the chick AV culture assay, conditioned media from Chinese
hamster ovary (CHO) cells stably expressing Xenopus
noggin appeared to disrupt later steps of E–M transforma-
tion, that is, invasion of the cells into collagen gels but not
the initial steps of E–M transformation, that is, cell–cell
separation (Romano and Runyan, 2000). Mouse endocardial
cells do not normally form a large endocardial epithelial
monolayer or display intermediate cell–cell separation be-
fore transformation, which is an obstacle in determining the
functional role of exogenously added proteins on the initial
steps of E–M transformation. However, because recombi-
nant human noggin (500 ng/ml) caused a substantial out-
growth of endocardial cells on the gel surface without cell–
cell separation when endocardial epithelium was cultured
with BMP-2 or associated AV myocardium (Figs. 3 and 4),
it is more likely that BMP-2 acted on a very early step of E–
M transformation (cell–cell separation) rather than a later
step of E–M transformation (invasive mesenchymal cell
formation) in mice.
In our mouse AV explant culture assays, recombinant
human noggin was applied at a final concentration of 500
ng/ml, which was sufficient to completely block E–M
transformation. However, this might not have been the case
in a recent experiment in which viruses were used to deliver
noggin. Retrovirally supported noggin expression experi-
ments in chick whole-embryo cultures caused abnormalities
of the septum and a decrease in the number of proliferating
mesenchymal cells of OT but, unlike our data, rarely
produced defects in AV cushion formation (Allen et al.,
2001). Although chick embryonic hearts showed extensive
Y. Sugi et al. / Developmental Biology 269 (2004) 505–518516viral infection after injection, it is possible that the virus did
not infect 100% of AV myocardial cells, and therefore
production of noggin may have been insufficient to com-
pletely block BMP pathways in the AV canal. This expla-
nation is further supported by evidence that an inhibition of
BMP-dependent events, such as the down-regulation of
Msx1, occurred in mesenchymal cells in the OT but not in
the AV canal mesenchyme after noggin virus infection.
TGFhs (Boyer et al., 1999a; Nakajima et al., 1994, 1998;
Potts and Runyan, 1989; Potts et al., 1991; Ramsdell and
Markwald, 1997; Romano and Runyan, 2000) and their
receptors (Brown et al., 1996, 1999; Boyer and Runyan,
2001; Boyer et al., 1999b; Lai et al., 2000) are the most
well-documented factors implicated in AV cushion mesen-
chymal cell formation and migration. In chick embryos,
endocardial epithelial cells, upon activation by myocardial
signaling, appear to express TGFhs as part of an in vivo
autocrine mechanism for regulating the transformation from
epithelial to mesenchymal phenotype in AV endocardial
cells (Nakajima et al., 1994, 1998; Ramsdell and Markwald,
1997). In mouse, TGFh-2 has been localized in AV myo-
cardium before AV transformation and in AV cushion
mesenchyme after E–M transformation (Camenisch et al.,
2002; Dickson et al., 1993; Molin et al., 2003). In a recent
publication, studies on AV endocardial morphogenesis in
mice revealed that only TGFh-2 but not TGFh-3 was
expressed at a time coincident with AV E–M transformation
and was obligatory for endocardial cushion cell transforma-
tion (Camenisch et al., 2002). Expression of TGFh-2
becomes enhanced in cushion mesenchyme during early
AV cushion development in mice (Camenisch et al., 2002).
The observation that TGFh-2 is detected in the AV myo-
cardium as well as in transformed mesenchymal cells
suggests that TGFh-2 may have an autocrine function in
addition to its paracrine pathway. Thus, up-regulation of
TGFh-2 in endocardial cells may be a potent key step of AV
E–M transformation in mice. Therefore, we sought to
determine the interactions between BMP signaling and
endocardially expressed TGFh-2 during AV E–M transfor-
mation. In our present mouse data, BMP-2, as well as
cocultured AV myocardium, promoted expression of
TGFh-2 in endocardial cells coincident with E–M transfor-
mation. Noggin inhibited an increase of TGFh-2 expression
in AV endocardial cells and E–M transformation in the
presence of associated AV myocardium or exogenously
added BMP-2 (Figs. 6 and 7). These data indicate that
myocardially derived BMP-2 can regulate TGFh-2 expres-
sion in AV endocardium and E–M transformation.
There may be several possible signaling pathways related
to the up-regulation of endocardial TGFh-2. For example,
myocardially derived BMP-2 might directly regulate TGFh-
2 expression in the endocardium in the AV canal through a
paracrine pathway or myocardial BMP-2 could induce
TGFh-2 or other regulatory molecules in the AV myocar-
dium through autocrine pathways, which subsequently reg-
ulated endocardial expression of TGFh-2. The latterpossibility is supported by the recent data that conditional
deletion of the BMP receptor-1A (ALK3) from the myocar-
dium in mice exhibited a decrease in TGFh-2 in the
myocardium adjacent to the AV canal (Gaussin et al.,
2002). In these mutant mice, an autocrine loop of BMP-2
in the myocardium was supposed to be blocked by the
deletion of the BMP receptor in the myocardium. This
conditional deletion caused defects in the fusion of AV
cushions and formation of the interventricular septum and
trabeculae. However, in the mutant mice, E–M transforma-
tion did occur, presumably because myocardial BMP-2 or
some other secreted proteins directly affected AV endocar-
dium through a paracrine pathway for E–M transformation.
Our data from the in vitro culture assay and the genetic
deletion data from Gaussin et al. (2002) both suggest that
TGFh-2 is a potential downstream target of BMP signaling
in AV cushion formation in mice. Taken together, our mouse
data suggest that BMP-2 is a part of myocardially derived
paracrine signaling pathway to potentially induce autocrine
pathways of TGFh-2 in target AVendocardial cells followed
by their transformation into cushion mesenchymal cells.
Since BMP-2 is expressed in transformed cushion mesen-
chyme and expression is sustained up to the later valvulo-
genesis stage, it might be of interest to determine if the
expression of BMP-2 is related to later morphologic events
during mouse AV morphogenesis.Acknowledgments
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